
CME Group Inc. (CME)
$
293.78
-3.80 (-1.29%)
Key metrics
Financial statements
Free cash flow per share
11.6608
Market cap
105.4 Billion
Price to sales ratio
16.1574
Debt to equity
0.1308
Current ratio
92.9677
Income quality
1.0503
Average inventory
0
ROE
0.1448
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. The company achieved a significant net income of $4,044,400,000.00 showcasing its strong financial health. The earnings per share (EPS) is reported at $11.18 indicating the company's profitability on a per-share basis. In terms of operational overhead, the company reported selling, general, and administrative expenses of $150,500,000.00 illustrating its cost management. The weighted average number of diluted shares outstanding is 360,233,000.00 reflecting potential dilution effects that investors may consider. Additionally, the company earned an interest income of $0.00 showcasing its financial investments that complement its core activities. CME Group offers a diverse array of futures and options products based on various financial instruments, serving a wide range of clientele including professional traders, institutions, and governments. Founded in 1898 and headquartered in Chicago, Illinois, it made its strategic name change from Chicago Mercantile Exchange Holdings Inc. to CME Group Inc. in July 2007. In terms of market performance, the stock is priced at $261.53 positioning it in the higher-end market. With a large market capitalization of $105,355,971,160.00 the company is a dominant player in the industry, specifically within the Financial - Data & Stock Exchanges sector, driving innovation and growth. The stock has a high average trading volume of 2,199,293.00 indicating strong liquidity that enhances investor participation. As a key player in the Financial - Data & Stock Exchanges industry, CME Group contributes significantly to the overall market landscape, leveraging its portfolio of products and services, including clearing house services, trade processing, and a wide range of market data services. By providing these essential services alongside its trading platforms, the company solidifies its role in the financial ecosystem, catering to a diverse clientele of corporations, manufacturers, investors, and central banks.
Investing in CME Group Inc. (CME) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict CME Group Inc. stock to fluctuate between $248.53 (low) and $329.16 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-03-27, CME Group Inc.'s market cap is $105,355,971,160, based on 358,622,000 outstanding shares.
Compared to JPMorgan Chase & Co., CME Group Inc. has a Lower Market-Cap, indicating a difference in performance.
CME Group Inc. pays dividends. The current dividend yield is 3.66%, with a payout of $7.45 per share.
To buy CME Group Inc. (CME) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CME. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
CME Group Inc.'s last stock split was 5:1 on 2012-07-23.
Revenue: $6,520,600,000 | EPS: $11.18 | Growth: 15.38%.
Visit https://www.cmegroup.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $329.16 (2026-03-03) | All-time low: $166.55 (2023-01-03).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

zacks.com
CME shows steady growth, strong dividends, and resilience, but with limited upside at current valuations, investors may consider holding the stock for now.

businesswire.com
WALTHAM, Mass.--(BUSINESS WIRE)-- #ai--Wolters Kluwer Health announced today that clinicians using UpToDate Expert AI can now earn Continuing Medical Education (CME) credit directly within their clinical workflow. When users ask clinical questions or engage in dialogue with UpToDate Expert AI, eligible activity can be captured for CME, enabling clinicians to earn and track credit as part of routine point-of-care decision-making. By integrating CME credit into the AI experience, Wolters Kluwer aims to.

prnewswire.com
CHICAGO, March 11, 2026 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2026 before the markets open on Wednesday, April 22, 2026. Written highlights for the quarter will be posted on the company's website at 6:00 a.m.

prnewswire.com
CHICAGO, March 9, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its energy complex reached a new single-day volume record of 8.3 million contracts on March 6, surpassing the previous daily record of 7.9 million contracts set on March 3, 2026. "As geopolitical shifts drive uncertainty throughout the global energy sector, market participants are turning to CME Group to manage their risk," said Peter Keavey, Global Head of Energy Products at CME Group.

prnewswire.com
CHICAGO and SINGAPORE, March 9, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced a total of 100 contracts of the South Asia Crude Palm Oil (Fastmarkets) futures traded as a block between Avere Commodities and Olam Agri, brokered by ICAP, on March 5, 2026. CME Group launched its four new South Asia edible oil futures contracts, which are available for trading, on March 2, 2026.

zacks.com
CME (CME) reported earnings 30 days ago. What's next for the stock?

seekingalpha.com
CME Group Inc. (CME) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript

prnewswire.com
CHICAGO, March 3, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its Dairy futures and options products set a new open interest (OI) record of 403,113 contracts on February 27. In addition, Dairy futures and options reached a new record monthly average daily volume (ADV) of 11,234 contracts in February.

prnewswire.com
Record ADV in interest rate products, including U.S. Treasury futures and options Record ADV in agricultural products Record international ADV of 11.6 million contracts CHICAGO, March 3, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its average daily volume (ADV) reached a new monthly record of 37.6 million contracts in February, an increase of 14% year-over-year. The company's previous monthly ADV record was set in April 2025 with 35.9 million contracts.
See all news